| Metric | Q3 2026 | Q3 2025 |
|---|---|---|
| Revenue | 6.6 | 8.5 |
| Gross profit | 3.1 | 5.1 |
| Profit before tax | -9.3 | 0.6 |
| Net income | -7.1 | 0.5 |
| EPS (diluted, $ a share) | $-0.11 | $0.01 |
A dash means the filing did not report that period. Growth is not shown when either period was a loss. Figures from the filing's XBRL data.
| Revenue, year on year | -22.4% |
|---|---|
| Gross margin | 46.5% |
10-Q filed with the SEC, NASDAQ: HIT. Figures from the filing's XBRL data; summary written with AI assistance from the filing.
Health In Tech, Inc.: key numbers
- Share price
- $0.3816Close, Nov 17
- Sector
- Finance
- Industry
- Insurance Agents, Brokers & ServiceSIC 6411
Today's reference numbers, updated daily. Not a valuation or a recommendation.
More from Health In Tech, Inc.
All →Health In Tech Investor Presentation
Health In Tech, Inc. has prepared a formal investor presentation deck to be used by management at upcoming conferences and meetings. The presentation highlights the company's AI-powered marketplace platform designed to help small- and medium-sized businesses access self-funded health plans. The filing includes the full slide deck as Exhibit 99.1 for investor review.
Health In Tech Leadership Change
Health In Tech, Inc. announced a leadership transition separating the roles of Executive Chairman and Chief Executive Officer. Founder Tim Johnson will serve as Executive Chairman focusing on long-term strategy and innovation, while Sanjay Shrestha has been appointed as the new CEO to lead day-to-day operations and commercial execution.
Health In Tech Financial Results
Health In Tech reported Q3 2026 revenue of $6.6 million and a net loss of $7.1 million, which included a $5.3 million provision for credit losses. The company highlighted a 15.9% year-over-year growth in distribution partners and a revenue pipeline of $156.4 million as of late October.
- Term
- Q3 2026
“It is a privilege to lead Health In Tech into its next chapter, and I want to thank Tim Johnson, our founder and Executive Chairman, and the Board for their confidence. Throughout my career, I have focused on scaling businesses, developing growth strategies, and leveraging capital markets to support long-term value creation. I have substantial operational experience scaling new products from incubation to meaningful commercial scale, building”
Sanjay Shrestha, Chief Executive Officer of Health In Tech
Health In Tech Shareholder Meeting
Health In Tech held its 2026 Annual Meeting of Stockholders where shareholders elected five directors and approved an amendment to increase authorized capital stock from 220 million to 720 million shares. Additionally, stockholders approved the potential issuance of Class A Common Stock under a Standby Equity Purchase Agreement and an amendment to the 2024 Equity Incentive Plan to increase authorized shares to 30.7 million.
Health In Tech $3M Debt Financing with YA II PN, Ltd.
Health In Tech, Inc. issued a second promissory note to YA II PN, Ltd. in the aggregate principal amount of $3.0 million, resulting in gross proceeds of $2.85 million after a 5% purchase price discount. The note matures on February 18, 2028, bears interest at 8.75% per annum, and is convertible into Class A Common Stock at a fixed price of $1.5735 per share.
- Value
- $3M
- Counterparty
- YA II PN, Ltd.
- Term
- through Feb 2028
Health In Tech Executive Compensation
Health In Tech appointed Sanjay Shrestha as Chief Executive Officer, succeeding founder Tim Johnson who transitioned to Executive Chairman. Mr. Shrestha's employment agreement includes a $500,000 base salary (increasing to $700,000 upon a $10M capital raise), eligibility for a cash bonus up to 200% of salary, and various equity awards.
- Counterparty
- Sanjay Shrestha